High-quality medicines for changing patient needs
We supply a broad range of injectable medicines to treat diseases across therapeutic categories that include anti-infectives, pain management, central nervous system and oncology. Globally, we supply over 300 generic injectable medicines. We are also developing a growing pipeline of new products.
Related news
Hikma launches Thiamine Hydrochloride Injection, USP
18 February 2021
Hikma launches Ephedrine Sulfate Injection, USP
4 February 2021
Hikma provides update on generic Advair Diskus® launch
15 January 2021